ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Novel effects of vericiguat, alone and combined with high-intensity interval training, on brain function in mice with breast cancer: a histopathological and behavioral study.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Vericiguat as an adjunct to temozolomide therapy improves behavioral and tumor outcomes in experimental glioblastoma.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is one of the most common types of cancer in women. High-intensity interval training (HIIT) and vericiguat, as therapeutic methods, have the potential to reduce and improve pathological conditions, as well as mitigate the side effects of standard treatments. Therefore, this study investigated the combined impact of HIIT and vericiguat on anxiety-related behaviors, motor activity, social interactions, and pathological changes in a female mouse model with breast cancer. In this experimental study, 70 female mice were randomly divided into seven groups: a control group (PBS), a breast cancer group (BC) (a mouse model of 4T1 breast cancer), a treatment control group (Vehicle), a group that performed HIIT, a group treated with vericiguat (administered orally for 6 weeks), and a group that performed HIIT and treated with vericiguat. Anxiety-like and social behaviors were assessed. Also, histopathological indicators, tumor volume, and survival rate were evaluated. The results showed that the BC group had a lower open arm time (OAT) (p < 0.05) and open arm entrance (OAE) (P < 0.05) indiced in the elevated plus maze (EPM) test and lower motor activity (P < 0.001) in the open field test (OFT) compared with PBS group, which indicated higher levels of anxiety. In addition, disturbance in the social behavior was seen in BC. The HIIT, vericiguat, and their combination improved these indices. Histopathologically, the HIIT and vericiguat groups showed lower tumor cellularity, mitotic index, metastasis, and higher necrotic foci, compared to the BC group. In conclusion, These findings suggest a potential synergistic benefit of HIIT and vericiguat in modulating behavioral and tumor-related brain pathology in breast cancer.
Indexed as
Identifiers
41249513What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.